Company · CIK 1751912

# NERVGEN PHARMA CORP.

| CIK | [1751912](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001751912) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Listed | NGEN (Nasdaq) |
| First annual or quarterly report | 2026-03-31 |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1751912/999999999526001763/9999999995-26-001763-index.htm) Declared effective | 333-296217 | 9999999995-26-001763 |
| 2026-01-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1751912/999999999526000094/9999999995-26-000094-index.htm) Declared effective | 333-292197 | 9999999995-26-000094 |

[All filings of this company](https://equitycapital.markets/filings?cik=1751912) · [CSV](https://equitycapital.markets/filings.csv?cik=1751912)

---
Source page: https://equitycapital.markets/company/1751912 · Data: U.S. SEC EDGAR · CC BY 4.0